LSD Effective in Treating Anxiety, Phase II Clinical Trial Shows (2024)
LSD Effective in Treating Anxiety, Phase II Clinical Trial Shows (2024)
A new drug known as MM-120, which is a more pharmacologically optimized version of LSD, seems effective for treating anxiety.
Yay!
So it's MindMed using their own analog of LSD-25 called MM-120 (lysergide d-tartrate)
"MM-120 (lysergide d-tartrate) is a new drug developed by MindMed, a biotech company the focuses on psychedelic-based medications. This drug is a “new and improved” version of LSD that is currently undergoing clinical trials for the treatment of generalized anxiety disorder (GAD). The most recent results from phase II of testing found that the drug candidate, particularly at the 100 µg dose, “demonstrated effectiveness, significantly reducing anxiety symptoms.”"
... without psychotherapy, which is HUGE
"MM-120 is the closest we’ve ever had to a clinically-proven and FDA-approved LSD-based medication. Phase II trials are currently underway, so it’s well on the path to becoming available via prescriptions in select markets, although it could still be some time before we can expect more widespread use of this drug. "